Versican expression is an adverse prognostic factor in MLL-rearranged infant acute lymphoblastic leukaemia

Autor:	Rob Pieters, Paola De Lorenzo, Ronald W. Stam, Maria Grazia Valsecchi, Pauline Schneider, Sandra S Mimoso Pinhancos, Emma M. C. Driessen
Přispěvatelé:	Pediatrics, Driessen, E, Pinhanços, S, Schneider, P, De Lorenzo, P, Valsecchi, M, Pieters, R, Stam, R
Rok vydání:	2015
Předmět:	0301 basic medicine Oncology Cancer Research medicine.medical_specialty Prognosi Angiogenesis Translocation Genetic 03 medical and health sciences 0302 clinical medicine Versicans Prostate Internal medicine medicine Humans Versican RNA Messenger Gene Gene Rearrangement biology business.industry Infant Newborn Cancer Infant Gene rearrangement Precursor Cell Lymphoblastic Leukemia-Lymphoma medicine.disease Prognosis Gene expression profiling 030104 developmental biology medicine.anatomical_structure 030220 oncology & carcinogenesis biology.protein Myeloid-Lymphoid Leukemia Protein business Human
Zdroj:	European Journal of Cancer, 57, 87-90. Elsevier Ltd.
ISSN:	1879-0852 0959-8049
Popis:	Acute lymphoblastic leukaemia (ALL) in infants (
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fda9db188e3163548557ec5d2356b0a https://pubmed.ncbi.nlm.nih.gov/26901613 Zobrazit plný text záznamu Full Text from ScienceDirect